Regulus Therapeutics Inc. is covered by the following analysts.
|Cantor Fitzgerald||Pete Stavropoulos, Ph.D.|
|Canaccord Genuity||Whitney Ijem|
|H.C. Wainwright||Raghuram Selvaraju, Ph.D.|
|Wells Fargo Securities||Yanan Zhu, Ph.D.|
Please note that any opinions, estimates or forecasts regarding Regulus Therapeutics Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Regulus Therapeutics Inc. or its management. Regulus Therapeutics Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.